£51.4 M

Quantum Pharma Revenue FY, 2017
Quantum Pharma Gross profit (FY, 2017)18.3 M
Quantum Pharma Gross profit margin (FY, 2017), %35.6%
Quantum Pharma Net income (FY, 2017)-10.9 M
Quantum Pharma EBITDA (FY, 2017)-9.2 M
Quantum Pharma EBIT (FY, 2017)-10 M
Quantum Pharma Cash, 31-Jan-20172.7 M

Quantum Pharma Income Statement

Annual

GBPFY, 2008FY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Revenue

29.7m35.0m33.4m35.2m41.0m47.3m47.5m51.4m

Revenue growth, %

15%13%

Cost of goods sold

18.1m18.0m17.8m19.2m23.8m26.5m29.7m33.0m

Gross profit

11.5m17.0m15.6m16.0m17.2m20.8m17.8m18.3m

Gross profit Margin, %

39%49%47%45%42%44%37%36%

Operating expense total

1.6m2.6m4.3m6.1m6.7m8.4m11.0m15.5m10.6m28.4m

EBITDA

2.4m5.9m7.5m11.2m9.2m8.0m6.6m5.8m7.9m(9.2m)

EBITDA margin, %

25%32%28%23%16%12%17%(18%)

EBIT

2.3m5.7m7.3m10.9m8.9m7.6m6.3m5.3m7.2m(10.0m)

EBIT margin, %

24%31%27%22%15%11%15%(20%)

Pre tax profit

2.2m5.6m7.3m10.9m9.0m6.8m8.1m5.7m7.9m(9.4m)

Income tax expense

(719.0k)(1.6m)(2.1m)(3.1m)(1.9m)(2.2m)(799.0k)(888.0k)(1.3m)(1.5m)

Net Income

1.5m4.0m5.1m7.8m7.0m4.6m7.3m4.8m6.6m(10.9m)

Quantum Pharma Balance Sheet

Annual

GBPFY, 2006FY, 2007FY, 2008FY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

351.9k855.7k983.0k2.5m1.9m3.6m2.5m4.4m2.7m2.2m1.9m2.7m

Accounts Receivable

1.9m5.2m6.2m6.5m6.0m7.4m6.2m7.2m6.7m6.4m

Inventories

66.8k82.0k213.0k323.0k466.0k512.0k497.0k743.0k1.0m1.7m1.9m1.5m

Current Assets

937.9k2.0m3.1m8.3m9.0m11.6m13.0m19.9m22.9m27.9m33.7m34.4m

PP&E

80.8k131.7k1.1m1.0m2.6m2.6m4.9m2.3m2.3m3.4m3.9m2.9m

Goodwill

93.0k

Total Assets

1.0m2.2m4.2m10.3m11.9m16.2m20.4m40.1m49.9m70.0m76.3m67.0m

Accounts Payable

889.0k2.1m2.9m3.7m4.8m3.9m4.2m3.9m4.8m5.6m

Current Liabilities

814.8k1.6m3.0m6.7m7.6m9.6m10.3m28.7m33.1m50.6m50.2m51.3m

Non-Current Liabilities

24.8k37.2k102.0k106.0k127.0k87.0k3.0k175.0k180.0k161.0k

Total Liabilities

839.5k1.6m3.1m6.9m7.8m9.7m10.3m28.7m33.1m50.7m50.4m51.5m

Additional Paid-in Capital

1.0k1.0k1.0k1.0k1.0k1.0k1.0k1.0k1.0k1.0k1.0k1.0k

Retained Earnings

531.0k2.4m645.0k2.3m2.5m93.0k4.3m1.8m6.6m(10.9m)

Total Equity

179.2k517.3k1.1m3.5m4.1m6.5m10.1m11.3m16.8m19.3m25.9m15.5m

Financial Leverage

5.7 x4.2 x3.8 x3 x2.9 x2.5 x2 x3.5 x3 x3.6 x2.9 x4.3 x

Quantum Pharma Cash Flow

Annual

GBPFY, 2008FY, 2009FY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

1.5m4.0m5.1m7.8m7.0m4.6m7.3m4.8m6.6m(10.9m)

Cash From Operating Activities

2.4m5.2m

Dividends Paid

974.0k1.6m4.5m5.5m4.5m4.5m3.0m3.0m

Net Change in Cash

127.0k1.5m

Income Taxes Paid

(799.0k)(888.0k)(1.3m)

Quantum Pharma Ratios

GBPY, 2017

Revenue/Employee

117.5k

Financial Leverage

4.3 x
Report incorrect company information